switching from semaglutide to tirzepatide reviews vs. for Weight Loss Switching from Semaglutide to Tirzepatide:

Spears , the CMO, brings a background in emergency medicine and clinical research in hormone and peptide therapy, providing board-certified oversight with a focus on evidence-based guidance and long-term health outcomes rather than simply prescription volume

Chen, Y., Dey, R

In April 2026, CMS announced it would not move forward with the Part D portion of BALANCE in 2027, citing the need for more data and a smoother transition

doi: 10.3892/ijmm.2015.2148 67 RockKLKataokaHLaiJJ

BALANCE Model: State Medicaid Program Participation Notably, the BALANCE Model also includes a Medicaid component, under which State Medicaid agencies can apply to participate before the July 31, 2026 deadline and on a case-by-case basis through January 1, 2027